Faculty Bibliography

A day after U.N. scientists reported that mother-to-infant transmission of the AIDS virus could be cut significantly by a simple drug treatment regimen, serious questions about its safety arose from a report of the deaths of two babies in a similar, separate French study. Both babies died from a rare neurological disease, French scientists reported Tuesday at a meeting in Chicago. Researchers involved said the meeting's organizers did not allow them to release news of the two cases until Tuesday, although the U.N. scientists reported the findings of their study Monday and also spoke at a news conference

United Nations scientists reported Monday that a simple, relatively inexpensive drug treatment can significantly reduce mother-to-infant transmission of the AIDS virus. The results are not as good as those from the standard treatment in Western countries, where prospective mothers infected with the virus receive the drug AZT starting at about the 26th week of pregnancy, and their babies take it for the first six weeks of life

CHICAGO - A simple, relatively inexpensive drug treatment can significantly reduce mother-to-infant transmission of the AIDS virus, U.N. scientists reported Monday. It could save hundreds of thousands of newborns in developing countries from an early death. The results are not as good as those from the standard treatment in Western countries, where prospective mothers infected with the virus receive the drug AZT starting at about the 26th week of pregnancy and their babies take it for the first six weeks of life. The new strategy, which requires taking one pill combining two drugs twice a day, significantly abbreviates the treatment period. It worked about as well whether the women started taking the pills about three weeks before delivery or at the onset of labor, which in many poor countries is the first time expectant mothers seek medical assistance. In either case, the mother and baby took the drugs for only a week after birth

CHICAGO - United Nations scientists reported here on Monday that a simple, relatively inexpensive drug treatment can significantly reduce mother-to-infant transmission of the AIDS virus. The results are not as good as those from the standard treatment in Western countries, where prospective mothers infected with the virus receive the drug AZT starting at about the 26th week of pregnancy and their babies take it for the first six weeks of life. The new strategy, which requires taking one pill combining two drugs twice a day, significantly abbreviates the treatment period. It worked about as well whether the women started taking the pills about three weeks before delivery or at the onset of labor, which in many poor countries is the first time expectant mothers seek medical assistance

United Nations scientists reported here today that a new, simple and relatively inexpensive drug treatment program can significantly reduce mother-to-infant transmission of the AIDS virus. The results are not as good as those from the standard treatment in Western countries, where prospective mothers infected with the virus receive the drug AZT daily, starting at about the 26th week of pregnancy, and their babies take it for the first six weeks of life. Dr. Joseph Saba, who reported the findings, expressed hope that the new strategy will sharply reduce the number of babies who are born infected with H.I.V. each year. Without drug treatments, as many as a quarter of infants born to infected women turn out to carry the AIDS virus -- about 600,000 babies year, health experts estimate. The United Nations estimates that 30 million people in the world are infected with H.I.V., and the number is growing

United Nations scientists reported Monday that a simple, relatively inexpensive drug treatment can significantly reduce mother-to-infant transmission of the AIDS virus. The results are not as good as those from the standard treatment in Western countries, where prospective mothers infected with the virus receive the drug AZT starting at about the 26th week of pregnancy, and their babies take it for the first six weeks of life. The new strategy, which requires taking one pill combining two drugs twice a day, significantly abbreviates the treatment period. It worked about as well whether the women started taking the pills about three weeks before delivery or at the onset of labor, which in many poor countries is the first time expectant mothers seek medical assistance. In either case, the mother and baby took the drugs for only a week after birth

United Nations scientists reported here yesterday that a simple, relatively inexpensive drug treatment can significantly reduce mother-to-infant transmission of the AIDS virus. The results are not as good as those from the standard treatment in Western countries, where prospective mothers infected with the virus receive the drug AZT starting at about the 26th week of pregnancy and their babies take it for the first six weeks of life

CHICAGO -- The riddle of the origin of the AIDS virus has apparently been solved, according to an international team of scientists who reported Sunday that they had traced its roots to a related virus in a subspecies of chimpanzee in Africa. The researchers, who reported their findings at the opening session of a scientific meeting in Chicago, said the simian virus was closely related to HIV-1, the type of AIDS virus that has caused the overwhelming majority of cases in the world. Since the virus jumped to humans, perhaps through exposure to blood in hunting or handling the meat of chimpanzees, it has been transmitted among humans to infect an estimated 30 million people in the world. Although scientists have long suspected that HIV-1 came from the chimpanzee, they have not been able to identify the precise subspecies until now. The subspecies is known as Pan troglodytes troglodytes, and the chimpanzee virus is known as SIVcpz, for simian immunodeficiency virus chimpanzee